News | November 29, 2016

MPI Research Appoints Vice President Of Operations

Source: MPI Research

MPI Research recently announced it has namedSusan L. Buckham, MS, as its new Vice President of Operations. In this role, Susan will be responsible for the strategic leadership and overall direction of operational activities for all functional areas involved with the coordination and execution of in vivo studies. In addition, she is responsible for allocating resources for growth and profitability and will ensure these needs are aligned with the business goals, while driving continuous improvement in compliance, quality and financial performance.

Susan brings 30 years of life science experience to this position, working in Animal and Human Health Research and Development and Food Safety. Most recently, she served as Executive Director for the Battle Creek Area Math and Science Center.  Previously, as Director of Analytical Services for Pfizer, Susan served as team lead for the creation and operations of two world-class GLP drug safety formulation and analytical labs (Kalamazoo, Mich., and Sandwich, UK). As Site Head for Covance, Susan led the build-out and operations of an ISO 17025 food safety testing laboratory in Battle Creek, Mich.  

“Susan’s industry knowledge and experience in strategic planning and leadership make her an exceptional asset to our organization,” said MPI Research President and CEO, Rob DeWit. “Our employees and Sponsors alike will benefit from her ability to identify organizational and process improvements to increase efficiencies and productivity at MPI Research.”

Susan has won several awards for her work including the 2011 Covance Way Award for Excellence in Leading Advancements of People, Process and Clients, as well as the 2007 Pfizer Global Research and Development Individual Achievement Award. She earned a Master of Science from Michigan State University and a Bachelor of Science from Wilmington College of Ohio.

About MPI Research
MPI Research, with global headquarters in Mattawan, Michigan, provides safety evaluation, discovery, bioanalytical, and analytical – and now phase I clinical – services to the biopharmaceutical, medical device, animal health, and chemical industries. The company also offers comprehensive imaging solutions including preclinical and clinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world. Learn more about how MPI Research can take you further at


Source: MPI Research